Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
AstraZeneca
Johnson and Johnson
Mallinckrodt
McKinsey

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

LIDOCAINE; TETRACAINE - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for lidocaine; tetracaine and what is the scope of freedom to operate?

Lidocaine; tetracaine is the generic ingredient in two branded drugs marketed by Taro Pharms and Galen Specialty, and is included in two NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Lidocaine; tetracaine has twenty-two patent family members in eleven countries.

There are twenty-nine drug master file entries for lidocaine; tetracaine. Three suppliers are listed for this compound.

Summary for LIDOCAINE; TETRACAINE
International Patents:22
US Patents:2
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: 29
Suppliers / Packagers: 3
Clinical Trials: 47
DailyMed Link:LIDOCAINE; TETRACAINE at DailyMed
Recent Clinical Trials for LIDOCAINE; TETRACAINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
McGill University Health CenterN/A
The Adelaide and Meath Hospital, incorporating The National Children's HospitalN/A
Cairo UniversityPhase 4

See all LIDOCAINE; TETRACAINE clinical trials

Pharmacology for LIDOCAINE; TETRACAINE

US Patents and Regulatory Information for LIDOCAINE; TETRACAINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro Pharms PLIAGLIS lidocaine; tetracaine CREAM;TOPICAL 021717-001 Jun 29, 2006 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Galen Specialty SYNERA lidocaine; tetracaine PATCH;TOPICAL 021623-001 Jun 23, 2005 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for LIDOCAINE; TETRACAINE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Galen Specialty SYNERA lidocaine; tetracaine PATCH;TOPICAL 021623-001 Jun 23, 2005   Start Trial   Start Trial
Taro Pharms PLIAGLIS lidocaine; tetracaine CREAM;TOPICAL 021717-001 Jun 29, 2006   Start Trial   Start Trial
Galen Specialty SYNERA lidocaine; tetracaine PATCH;TOPICAL 021623-001 Jun 23, 2005   Start Trial   Start Trial
Galen Specialty SYNERA lidocaine; tetracaine PATCH;TOPICAL 021623-001 Jun 23, 2005   Start Trial   Start Trial
Galen Specialty SYNERA lidocaine; tetracaine PATCH;TOPICAL 021623-001 Jun 23, 2005   Start Trial   Start Trial
Galen Specialty SYNERA lidocaine; tetracaine PATCH;TOPICAL 021623-001 Jun 23, 2005   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Express Scripts
McKinsey
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.